• DefenAge Clinical Study Offers Promising Evidence

    8 monthes ago - By Surgical Aesthetics Magazine

    Patients who used an antiaging skincare line containing alpha-defensin 5 and beta-defensin 3 for 12 weeks had significant improvement in fine lines, coarse wrinkles, pore size and visible pigmentation compared to those who received a placebo formulation, according to new study published in the Journal of Drugs in Dermatology .
    Amy Taub, MD, et al, performed a multi-center, double-blind, vehicle-controlled clinical trial that included 44 female subjects. Two thirds of subjects used the three-product DefenAge line and one-third received a placebo formulation. All subjects used the same daily...
    Read more ...